A glial-specific, repressible, adenovirus vector for brain tumor gene therapy

Cancer Research

Volumn 58, Issue 16, 1998, Pages 3504-3507

  Chen, Jun ^a   Bezdek, Trevor ^a   Chang, Jen ^a   Kherzai, Abdullah W ^a   Willingham, Timothy ^a   Azzara, Matthew ^a   Nisen, Perry D ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GLIAL FIBRILLARY ACIDIC PROTEIN; TETRACYCLINE; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; BRAIN CANCER; GENE THERAPY; GLIA; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; PRIORITY JOURNAL; TANDEM REPEAT;

ADENOVIRIDAE; ANTI-BACTERIAL AGENTS; BETA-GALACTOSIDASE; BRAIN NEOPLASMS; DEFECTIVE VIRUSES; GENE THERAPY; GENES, REPORTER; GENETIC VECTORS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; HUMANS; SENSITIVITY AND SPECIFICITY; TETRACYCLINE; TUMOR CELLS, CULTURED;

EID: 0032529233     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Takamiya, Y., Short, M. P., Moolten, F. L., Fleet, C., Mineta, T., Breakefield, X. O., and Martuza, R. L. An experimental model of retrovirus gene therapy for malignant brain tumors. J. Neurosurg., 79: 104-110, 1993.
2. Hoegler, D. B., and Davey, P. A prospective study of short course radiotherapy in elderly patients with malignant glioma. J. Neuro-Oncol., 33: 201-204, 1997.
3. Culver, K. W., Ram, Z., Wallbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
4. Klatzmann, D., Philippen, Valery, C. A., J., Bensimon, G., and Salzmann, J. Gene therapy for glioblastoma in adult patients: safety and efficacy evaluation of an in situ injection of recombinant retroviruses producing cells carrying the thymidine kinase 4 gene of the herpes simplex type 1 virus, to be followed with the administration of ganciclovir. Hum. Gene Ther., 7: 109-126, 1996.
5. Perez-Cruet, M. J., Trask, T. W., Chen, S-H., Goodman, J. C., Woo, S. L. C., Grossman, R. G., and Shine, H. D. Adenovirus-mediated gene therapy of experimental gliomas. J. Neurosci. Res., 39: 506-511, 1994.
6. Eng, L. F. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J. Neuroimmunol., 8: 203-214, 1985.
7. Besnard, F., Brenner, M., Nakatani, Y., Chao, R., Purohit, H. J., and Freese, E. Multiple interacting sites regulate astrocyte-specific transcription of the human gene for glial fibrillary acidic protein. J. Biol. Chem., 266: 18877-18888, 1991.
8. Fkuyama, K., Tabuchi, K., Matsuzawa, K., and Rutka, J. T. The glial cell specific expression vector using the GFAP promoter. Abstract of the 11th International Conference on Brain Tumor Research and Therapy, October, 1995, Napa, CA.
9. Fkuyama, K. Matsuzawa, K., Hubbard, S. L., Dirks, P. B., Murakami, M., and Rutka, J. T. Analysis of glial fibrillary acidic protein gene methylation in human malignant glioma. Anticancer Res., 16: 1251-1258, 1996.
10. Thomsen, D. R., Stenberg, R. M., Goins, W. F., and Stinski, M. F. Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proc. Natl. Acad. Sci. USA, 81: 659-663, 1984.
11. Gossen, M., and Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA, 89: 5547-5551, 1992.
12. Gluzman, Y., Reichl, H., and Solnick, D. In: Y. Gluzman (ed.), Eukaryotic Viral Vetors, pp. 187-192. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
13. Chen, J., Willingham, T., Margraf, L. R., Schreiber-Agus, N., DePinho, R. A., and Nisen, P. D. Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype of human brain tumour cells. Nat. Med., 1: 638-643, 1995.
14. kip1. J. Clin. Invest., 97: 1983-1988, 1996.
15. McGrory, W. J., Bautisita, D. S., and Graham, F. L. Virology, 163: 614-617, 1988.
16. Graham, F. L., and Prevec, L. Manipulation of adenovirus vectors. In: E. J. Murray (ed.), Methods in Molecular Biology, Vol. 7. Gene transfer and expression protocols, pp. 109-127. Clifton, NJ: The Humana Press, Inc., 1991.
17. Gomez-Foix, A. M., Coats, W. S., Baque, S., Alam, T., Gerard, R. D., and Newgard, C. B. Adenovirus-mediated transfer of muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J. Biol. Chem., 267: 25129-25134, 1992.
18. Pizzo, P. A., and Poplack, D. G. Principles and Practice of Pediatric Oncology, Ed. 2, pp. 633-681. Philadelphia: J. B. Lippincott Co., 1993.
19. Teter, B., Osterburg, H. H., Anderson, C. P., and Finch, C. E. Methylation of the rat glial fibrillary acidic protein gene shows tissue-specific domains. J. Neurosci. Res., 39: 680-693, 1994.
20. Condorelli, D. F., Nicoletti, V. G., Barresi, V., Caruso, A., Conticelo, S., de Vellis, J., and Giuffrida Stella, A. M. Tissue-specific DNA methylation patterns of the rat glial fibrillary acidic protein gene. J. Neurosci. Res., 39: 694-707, 1994.